The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
about
HIV-1 neutralization profile and plant-based recombinant expression of actinohivin, an Env glycan-specific lectin devoid of T-cell mitogenic activityFew and far between: how HIV may be evading antibody avidityAntibody vs. HIV in a clash of evolutionary titansPrinted covalent glycan array for ligand profiling of diverse glycan binding proteinsComprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesA lectin isolated from bananas is a potent inhibitor of HIV replicationPolyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individualsNeutralizing antibody and anti-retroviral drug sensitivities of HIV-1 isolates resistant to small molecule CCR5 inhibitorsFrequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switchHyperglycosylated mutants of human immunodeficiency virus (HIV) type 1 monomeric gp120 as novel antigens for HIV vaccine designThe HIV glycan shield as a target for broadly neutralizing antibodiesRecent strategies targeting HIV glycans in vaccine designStructural insights on the role of antibodies in HIV-1 vaccine and therapyDesigning synthetic vaccines for HIVHIV-1 antibodies from infection and vaccination: insights for guiding vaccine designVaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding SiteAntigenic properties of the human immunodeficiency virus envelope glycoprotein gp120 on virions bound to target cellsAiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidatesStructures of the complexes of a potent anti-HIV protein cyanovirin-N and high mannose oligosaccharidesMultiple Modes of Binding Enhance the Affinity of DC-SIGN for High Mannose N-Linked Glycans Found on Viral GlycoproteinsA peptide inhibitor of HIV-1 neutralizing antibody 2G12 is not a structural mimic of the natural carbohydrate epitope on gp120Mechanism by which the lectin actinohivin blocks HIV infection of target cellsInteractions between Lipids and Human Anti-HIV Antibody 4E10 Can Be Reduced without Ablating Neutralizing ActivityAnti-HIV Activity of Defective Cyanovirin-N Mutants Is Restored by DimerizationCrystal Structure of the Neutralizing Llama VHH D7 and Its Mode of HIV-1 gp120 InteractionAntibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain ExchangedA nonself sugar mimic of the HIV glycan shield shows enhanced antigenicityComplex-type N-glycan recognition by potent broadly neutralizing HIV antibodiesViral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization BreadthBroadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding GlycansStructural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16Structural Basis for Enhanced HIV-1 Neutralization by a Dimeric Immunoglobulin G Form of the Glycan-Recognizing Antibody 2G12Trimeric HIV-1-Env Structures Define Glycan Shields from Clades A, B, and GAntiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory AntibodiesTargeting host-derived glycans on enveloped viruses for antibody-based vaccine designFine mapping of the interaction of neutralizing and nonneutralizing monoclonal antibodies with the CD4 binding site of human immunodeficiency virus type 1 gp120.Structural Constraints Determine the Glycosylation of HIV-1 Envelope TrimersCell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 EnvelopeGlycan clustering stabilizes the mannose patch of HIV-1 and preserves vulnerability to broadly neutralizing antibodiesThe good and evil of complement activation in HIV-1 infection
P2860
Q21076115-AE57D3F8-3E9F-44C0-AFE9-EFD4CB956BBFQ21090507-9C75FF0C-544B-43EA-BB3D-BD59D1CF9666Q24536059-8F6B642A-FE1B-4A33-B6FA-D503A3110FC8Q24559665-C0C168BC-AA95-4D9F-B54A-BA1D4AE4D44BQ24561905-D46FDD6A-AEE2-43FA-98EA-A1BD97E68AEEQ24629155-25F9FF5B-E96B-4F9D-8931-57E857776D7CQ24635002-BC02FE39-EEA7-4BD1-99A3-B2BF73784E04Q24655129-4545F704-4CB8-442D-BA7D-05BD7279DE2BQ24672335-11B24454-B068-4761-A589-8FD3DA727DFFQ24679395-5461B322-9470-4532-B67B-D2D53EDBA945Q26786540-0DBD6992-55F7-424D-94FD-156BDC1626F7Q26823603-A19F4F2D-CAD8-4FA3-BFA8-D30F740180B9Q26829461-E572036F-5872-41FF-A5AE-C48FCD8B957AQ26862617-77FB1AB4-106F-4B85-BA30-0C3C636F3D60Q27022055-006B74BA-D6E5-4346-AD20-BAFA9CEF6621Q27319450-E52B0DD0-066C-4A22-B1E6-3492D0A8F3FAQ27320687-97FCA26B-2171-466F-860F-F7AC5CD1F3EBQ27489000-6C44A629-E8A6-4E1E-BB02-562FC36F482DQ27639344-2B9B90D0-88B7-4E5A-B65F-135DD2640CB7Q27643229-3F781F18-8314-437C-AF6C-C98746C038E4Q27649541-484E575E-A2EB-4FED-B119-1DFCCB9E049AQ27657228-99DDC901-27DB-46A7-8B3F-FF7AE72E79A6Q27658138-94002944-432F-4D27-A5A9-6A98A2010454Q27659715-401EF464-FC17-44D1-8690-79613A226F81Q27661588-CC79467C-D325-4486-918D-CFF90078E2C4Q27664038-BBDAA406-2D09-49BD-8BA2-1FBABA7735D5Q27664589-B7E90B90-D1F4-45FD-94EE-BF0EB723EF10Q27674878-A8D1F141-4573-40EF-8EA4-B3C56250CCC6Q27676728-7FA88A78-7C3B-40CB-B05B-07934F6526DCQ27678062-E3EF1651-8A29-43AC-8E90-A01AE49442DDQ27678312-99FE803D-0E5B-4B3E-BA6B-0BDCD59A980EQ27680810-2E3DEBDF-B8F1-45F7-980F-EDFE4AC4C6CAQ27704710-2ECE991B-2DEC-421C-B7FC-B49DF05C2ED1Q28066335-4207268B-A3DC-40D0-AD9A-FE191CD9CF5BQ28084672-F2E4EFBD-9368-49EB-89B6-6E840DE8711CQ28217208-4E590865-86D4-40FA-B057-CA24783E2D84Q28263063-5F74CB38-62E5-4717-9DF7-8FF32D513B95Q28263655-85D0FCDF-C09B-4B5A-AC59-934364DC6896Q28263932-4C77F313-C5A9-4DC3-B4BF-11C756A9C525Q28275986-22E38281-9DF5-4152-861B-C68518D29308
P2860
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The broadly neutralizing anti- ...... es on the outer face of gp120.
@ast
The broadly neutralizing anti- ...... es on the outer face of gp120.
@en
The broadly neutralizing anti- ...... es on the outer face of gp120.
@nl
type
label
The broadly neutralizing anti- ...... es on the outer face of gp120.
@ast
The broadly neutralizing anti- ...... es on the outer face of gp120.
@en
The broadly neutralizing anti- ...... es on the outer face of gp120.
@nl
prefLabel
The broadly neutralizing anti- ...... es on the outer face of gp120.
@ast
The broadly neutralizing anti- ...... es on the outer face of gp120.
@en
The broadly neutralizing anti- ...... es on the outer face of gp120.
@nl
P2093
P2860
P1433
P1476
The broadly neutralizing anti- ...... es on the outer face of gp120.
@en
P2093
Christopher N Scanlan
Dennis R Burton
Hermann Katinger
Mark R Wormald
Pauline M Rudd
Ralph Pantophlet
Raymond A Dwek
Robyn Stanfield
P2860
P304
P356
10.1128/JVI.76.14.7306-7321.2002
P407
P577
2002-07-01T00:00:00Z